California Association
for
Medical Laboratory Technology

Distance Learning Program

A BACTERIAL CARCINOGEN - HELICOBACTER PYLORI by Lucy Treagan, Ph.D. Prof. Biol. Emerita University of San Francisco San Francisco, CA Course # DL-957 Approved for 2.0 CE/Contact Hours Level of Difficulty: Intermediate © California Association for Medical Laboratory Technology. Permission to reprint any part of these materials, other than for credit from CAMLT, must be obtained in writing from the CAMLT Executive Office. CAMLT is approved by the California Department of Health Services as a CA CLS Accrediting Agency (#0021) and this course is is approved by ASCLS for the P.A.C.E.® Program (#519) 1895 Mowry Ave, Suite 112 Fremont, CA 94538-1700 Phone: 510-792-4441 FAX:  510-792-3045 Notification of Distance Learning Deadline All continuing education units required to renew your license must be earned no later than the expiration date printed on your license. If some of your units are made up of Distance Learning courses, please allow yourself enough time to retake the test in the event you do not pass on the first attempt. CAMLT urges you to earn your CE units early!.

This course is configured to be completed on-line. You can register for the course, submit secure payment using a credit card via PayPal, take the quiz on-line and receive your graded score.   If you pass, your certificate will be mailed to you from the CAMLT office. If you fail, you must submit new payment and obtain a new PayPal receipt each time you take the test.   A certificate will be issued only if you have paid for re-taking the course and you pass the test. If you want to submit your registration and quiz via fax or mail you should print the Adobe Acrobat version of the course which includes the required Registration/Quiz form.

Links to: On-line REGISTRATION, PAYMENT and QUIZ Printable Acrobat version of this course * Other Distance Learning Courses

*Click on the link above to download the required free software from the Adobe website

A BACTERIAL CARCINOGEN - HELICOBACTER PYLORI

Completion of this course requires downloading the Acrobat Version (link above).
You may then print a copy or view the downloaded file on your computer to see the course material.
Only the Objectives and Introduction appear below.

OBJECTIVES:
Upon completion of this course the participant will be able to

• Describe the principal characteristics of Helicobacter pylori and its habitat
• Outline methods of isolation and identification
• Explain the role of H. pylori in human disease
• List suggested treatment protocol
• Describe virulence factors and discuss host response to infection
• List diagnostic methods currently in use
• Explain the epidemiology of infection in underdeveloped and in developed countries
• Discuss the current prevalence of infection and future trends
• List animal models of infection
• Outline the current status of vaccine development

INTRODUCTION AND HISTORICAL BACKGROUND
Infection with Helicobacter pylori is one of the most common bacterial infections of humans. The infection is generally acquired early in life and has a particularly high incidence in countries with poor hygiene conditions. The bacterium colonizes the gastric mucosa leading to a life-long infection. A minority of infected individuals develop serious gastrointestinal diseases: chronic gastritis, gastroduodenal ulcers, adenocarcinoma, and lymphoma.

Extensive seroepidemiologic studies have shown an increased risk of gastric cancer in persons infected with H. pylori. Based on such studies the International Agency for Research on Cancer classified H. pylori as a type I carcinogen in 1994 (1).

The association of H. pylori with the development of gastric and duodenal ulcers has had a profound impact on the diagnosis and treatment of upper gastroduodenal diseases; gastric ulcer is now regarded an infectious disease that can be controlled with antibiotic treatment.

 

Link to On-line REGISTRATION, PAYMENT and QUIZ to submit for credit